Mrv1909 11191922332D 9 9 0 0 0 0 999 V2000 -0.0078 -0.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5629 -1.3215 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.8273 -0.0132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1708 -0.7637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.1559 -0.9171 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.4043 0.6079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0078 1.3215 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.2317 0.6079 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.2317 0.7056 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 6 1 0 0 0 0 1 5 2 0 0 0 0 1 3 1 0 0 0 0 2 4 1 0 0 0 0 2 5 1 0 0 0 0 3 4 2 0 0 0 0 3 9 1 0 0 0 0 6 7 2 0 0 0 0 6 8 1 0 0 0 0 M END > DB02401 > drugbank > OC(=O)C1=NON=C1O > InChI=1S/C3H2N2O4/c6-2-1(3(7)8)4-9-5-2/h(H,5,6)(H,7,8) > IBRWUZLLHSXPKL-UHFFFAOYSA-N > C3H2N2O4 > 130.059 > 130.001456562 > 5 > 11 > 9.247065710295153 > 1 > 2 > 0 > 0 > 4-hydroxy-1,2,5-oxadiazole-3-carboxylic acid > 0.34 > 0.5464165369999999 > -0.45 > 0 > 1 > -2 > 3.0119243260688386 > 2.346754603297497 > -3.4730854433076765 > 96.45 > 25.6072 > 1 > 1 > 4.65e+01 g/l > 2lambda5-triaz-1-en-2-yn-1-ide hydrate diiron > 0 > DB02401 > EXPT02463 > experimental > 4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid $$$$